je.st
news
Home
› Certara Partners With Critical Path Institute To Develop Population-Based Lung Model To Test New Tuberculosis Drugs
Certara Partners With Critical Path Institute To Develop Population-Based Lung Model To Test New Tuberculosis Drugs
2013-10-02 05:59:57| drugdiscoveryonline News Articles
Certara, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, recently announced that it is partnering with the Critical Path Institute (“C-Path”) to develop a physiologically-based pharmacokinetic (PBPK) model of the human lung
Tags: test
model
partners
develop
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||